(2S)-2-(1H-indol-3-yl)hexanoic acid

(2S)-2-(1H-indol-3-yl)hexanoic acid Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name (2S)-2-(1H-indol-3-yl)hexanoic acid
Generic (2S)-2-(1H-indol-3-yl)hexanoic acid
Type
Formula C14H17NO2
Weight Average: 231.2903
Monoisotopic: 231.125928793
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
(2S)-2-(1H-indol-3-yl)hexanoic acid
(2S)-2-(1H-indol-3-yl)hexanoic acid

Innovators Monograph

You find simplified version here (2S)-2-(1H-indol-3-yl)hexanoic acid



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=24768549
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99443451
https://www.chemspider.com/Chemical-Structure.25058959.html
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/2S2
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

(2S)-2-(1H-indol-3-yl)pentanoic acid
(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid
(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol
2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid
2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
(R)-Atenolol
2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE
{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID
4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID
N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide
Sialogram
CEA blood test
Progesterone Test
Estrogen Receptor, Progesterone Receptor Tests
RBC urine test
Sinus x-ray
Parainfluenza Tests
Electroretinography
Reticulocyte Count
His bundle electrography
Locally advanced disease has progressed during or following platinum-containing chemotherapy urothelial carcinoma (UC)
Cyclic Vomiting Syndrome
locally advanced enteropancreatic neuroendocrine tumors
Appetite stimulation
High risk of fracture Osteoporosis
Epiglottitis
Discomfort
Acute monocytic leukaemia
Allergic Reaction
Preeclampsia